塔利多米德胚性病变的心血管表现
Peter Franz Klein-Weigel1, Christina Ding-Greiner2
1Clinic for Angiology and Diabetology, Helios Hospital Berlin-Buch, Germany.
VASA. Zeitschrift fur Gefasskrankheiten
|July 2, 2025
概括
thalidomide胚性病变可以导致心血管异常. 管理这些患者的医生应该考虑潜在的长期血管并发症和对心血管健康的影响.
科学领域:
- 心血管医学 心血管医学
- 医学史 医学史 医学史
- 胚胎学 胚胎学
背景情况:
- thalidomide (ConterganR) 的戒断发生在60多年前.
- 患有thalidomide胚性病变的患者正在衰老,增加了他们对医疗保健的需求.
- 在这个人群中,心血管健康仍然是专家们的重要关注点.
研究的目的:
- 在thalidomide胚胎病变中详细说明心血管异常.
- 为了确定疾病管理的临床相关特征.
- 调查受影响个体中动脉样硬化疾病的潜在增加发病率.
主要方法:
- 审查与thalidomide胚性病变相关的心血管异常.
- 对疾病管理影响的临床特征分析.
- 关于动脉样硬化疾病患病率的比较讨论.
主要成果:
- 心血管异常是thalidomide胚胎病症的一个关键特征.
- 特定的临床症状显著影响患者管理策略.
- 需要对动脉样硬化疾病的频率进行进一步的研究.
结论:
- 对医生来说,了解thalidomide胚性病的心血管影响至关重要.
- 与年龄相关的健康需求需要仔细管理血管和心脏问题.
- 泰利多米德胚性病变与动脉硬化之间的关系需要继续进行研究.
相关概念视频
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Cardiovascular System Abnormal Findings I: Inspection and Palpation
529
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Abnormal findings observed during an inspection
529
Endocarditis II: Clinical Features of Infective Endocarditis
28
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
28
Chronic Kidney Disease II: Clinical Manifestations
104
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
Coronary Artery Disease III: Clinical Manifestations
38
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
38
Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30


